| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 02/28/2013 | WO2013026099A1 Fn14 binding proteins and uses thereof |
| 02/28/2013 | WO2012174537A3 Small molecule screening for mouse satellite cell proliferation |
| 02/28/2013 | US20130053446 Pharmaceutical preparations having individualized dosage and structure |
| 02/28/2013 | US20130053389 Certain chemical entities, compositions and methods |
| 02/28/2013 | US20130053381 2,4-dioxo-1,4-dihydro-2h-quinazolin-3-yl-sulfonamide derivatives |
| 02/28/2013 | US20130053348 Certain chemical entities, compositions, and methods |
| 02/28/2013 | US20130053303 Compounds for enzyme inhibition |
| 02/28/2013 | US20130052274 Nutritional compositions including exogenous vitamin k2 |
| 02/28/2013 | US20130052184 Gelatinase inhibitors and prodrugs |
| 02/28/2013 | CA2845946A1 Fn14-binding proteins and uses thereof |
| 02/27/2013 | EP2560653A1 Certain amino-pyrimidines, compositions thereof, and methods for their use |
| 02/27/2013 | EP2560488A1 Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
| 02/27/2013 | CN102940849A Chinese medicine fumigation composition for adjunctive therapy of spastic cerebral palsy |
| 02/27/2013 | CN102940761A Traditional Chinese medicine for treating graphospasm |
| 02/27/2013 | CN102940755A Pill for treating acute lumbar sprain and preparation method |
| 02/27/2013 | CN102940745A Pill for treating blepharospasm |
| 02/26/2013 | US8383614 Hypercholestrolemia and tendinous injuries |
| 02/21/2013 | WO2013024898A1 Heterocyclic derivative and pharmaceutical drug |
| 02/21/2013 | WO2013024311A1 Amidoxime derivatives for the prevention and/or treatment of muscle atrophy |
| 02/21/2013 | US20130045963 Cyclohexyl Azetidine Derivatives as JAK Inhibitors |
| 02/21/2013 | US20130045218 Fc receptor binding proteins |
| 02/21/2013 | US20130045186 Method of Detecting and/or Identifying Adeno-Associated Virus (AAV) Sequences and Isolating Novel Sequences Identified Thereby |
| 02/21/2013 | US20130045183 Boswellia oil, its fractions and compositions for enhancing brain function |
| 02/21/2013 | CA2845516A1 Muscle tissue regeneration using muscle fiber fragments |
| 02/21/2013 | CA2844794A1 Heterocyclic derivative and pharmaceutical |
| 02/20/2013 | CN102935201A Chinese herbal preparation for treating hyperostosis, lumbar muscle degeneration, pain from rheumatism and the like |
| 02/19/2013 | US8377950 Crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/19/2013 | US8377865 Growth hormone releasing peptides |
| 02/19/2013 | CA2486187C Kinase inhibitors |
| 02/19/2013 | CA2469092C Copolymer 1 vaccine and methods for treatment of amyotrophic lateral sclerosis (als) |
| 02/14/2013 | WO2013023104A1 Chlorobis copper (i) complex compositions and methods of manufacture and use |
| 02/14/2013 | WO2013022052A1 Medicinal agent for medical applications, and method for searching for novel medicinal agent |
| 02/14/2013 | WO2013021891A1 Amino-acid-containing composition for enhancing recovery from muscle fatigue |
| 02/14/2013 | US20130041036 Ferulic acid as feed supplement in beef cattle to promote animal growth and improve the meat quality of the carcass and the meat |
| 02/14/2013 | US20130041007 Selective Androgen Receptor Modulators |
| 02/14/2013 | US20130040971 6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders |
| 02/14/2013 | US20130040962 P38 MAP Kinase Inhibitors |
| 02/14/2013 | US20130040901 Mitochondrial-targeted antioxidants protect against mechanical ventilation-induced diaphragm dysfunction and skeletal muscle atrophy |
| 02/14/2013 | US20130039981 Quick Dissolving, Long Acting Zinc Therapeutic Formulations |
| 02/14/2013 | US20130039979 Medication on the basis of 3,3'-diindolylmethane (dim) with high-bioavailability and its use in treatment of human hyperplastic and inflammatory diseases |
| 02/14/2013 | US20130039892 Adherent stromal cells derived from plancentas of multiple donors and uses thereof |
| 02/14/2013 | US20130039889 Recombinant microorganisms |
| 02/14/2013 | CA2844672A1 Chlorobis copper (i) complex compositions and methods of manufacture and use |
| 02/13/2013 | EP2556083A2 Non-hormonal steroid modulators of nf- kappa b for treatment of disease |
| 02/13/2013 | CN102933602A Antibodies to human GDF8 |
| 02/13/2013 | CN102933548A Carboxamide compounds and their use as calpain inhibitors |
| 02/13/2013 | CN102933224A Compounds for use in the treatment of diseases based on the expression of toxic transcripts |
| 02/13/2013 | CN102925291A Variable pressure distillation method for extracting pythoncidere and essential oil from Chamaecyparis plants |
| 02/13/2013 | CN102920992A Injection recombinant follistatin preparation and preparation method |
| 02/13/2013 | CN102920974A External medicine composition used for military, sports, surgical, and orthopedic traumas |
| 02/13/2013 | CN102920822A Pyriformis syndrome treatment prescription |
| 02/13/2013 | CN101282992B 抗肌抑制素抗体 Anti-myostatin antibodies |
| 02/12/2013 | US8372413 Mycobacterial disease, malaria, leishmaniasis, toxoplasmosis, schistosomiasis and clonorchiasis; antiallergens; asthma |
| 02/12/2013 | CA2416988C Leucine-based motif and clostridial neurotoxins |
| 02/12/2013 | CA2365903C Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine |
| 02/07/2013 | WO2013018695A1 Heterocyclic compound |
| 02/07/2013 | WO2013017672A1 Mammal sestrins in the treatment of muscle wasting |
| 02/07/2013 | US20130035387 Sarms and method of use thereof |
| 02/07/2013 | US20130035338 Eyelid treatment |
| 02/07/2013 | US20130035333 Use of cinnabarinic acid as a modulator of immune responses in autoimmune disorders |
| 02/07/2013 | US20130034569 Il-18 receptor antigen binding proteins |
| 02/07/2013 | US20130034562 Selective androgen receptor modulators for treating diabetes |
| 02/06/2013 | EP2554541A1 Therapeutic agent or prophylactic agent for fibromyalgia |
| 02/06/2013 | EP2554182A1 Mammal sestrins in the treatment of muscle wasting |
| 02/06/2013 | EP2554180A1 Compounds for use in the treatment of diseases based on the expression of toxic transcripts |
| 02/06/2013 | EP2552475A1 Botulinum toxin dosage regimen for chronic migraine prophylaxis |
| 02/06/2013 | EP2552435A1 Methods and compositions comprising ampk activator (metformin/troglitazone) for the treatment of myotonic dystrophy type 1 (dm1) |
| 02/06/2013 | CN102917728A Botulinum toxin dosage regimen for chronic migraine prophylaxis |
| 02/06/2013 | CN102917703A Novel EP4 agonist |
| 02/06/2013 | CN102908533A Preparation method for pine leaf and notopterygium root wine |
| 02/06/2013 | CN102908509A Drug for treating child acute benign myositis |
| 02/06/2013 | CN102908442A Composition for treating traumatic injuries and medicinal liquor thereof |
| 02/05/2013 | US8367631 Pharmaceutical composition which improves in vivo gene transfer |
| 02/05/2013 | US8367100 Preparation and use of sleeve and micro-encapsulated topical analgesic patch for treating pain |
| 01/31/2013 | WO2013014565A1 Compositions and methods for the treatment of metabolic conditions and muscular disorders |
| 01/31/2013 | US20130030052 Compositions and methods for the sustained release of beta-alanine |
| 01/31/2013 | US20130030040 Methods and compositions for increasing sialic acid production and treating sialic related disease conditions |
| 01/31/2013 | US20130030025 Use of potassium channel blockers to treat cerebral palsy |
| 01/31/2013 | US20130030014 N-(IMIDAZOLIDIN-2-YLIDENE)-HETEROCYCLOPENTA[b]PYRIDINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS |
| 01/31/2013 | US20130029994 N-(imidazolidin-2-ylidene)quinoline derivatives as modulators of alpha 2 adrenergic receptors |
| 01/31/2013 | US20130029949 Substituted Quinolines and Their Use As Medicaments |
| 01/31/2013 | US20130029924 Glycosylated valproic acid analogs and uses thereof |
| 01/31/2013 | US20130029908 Cerberus/coco derivatives and uses thereof |
| 01/31/2013 | US20130028968 Compositions and methods to relieve chronic diseases symptoms |
| 01/31/2013 | US20130028912 Tweak/fn14 system regulates skeletal muscle atrophy and regeneration |
| 01/31/2013 | US20130028869 Feed supplement comprising oligosaccharides and medium chain fatty acids |
| 01/31/2013 | US20130028860 Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue and/or fever |
| 01/31/2013 | CA2842798A1 Recombinant virus products and methods for inhibition of expression of dux4 |
| 01/30/2013 | CN102898370A Cis-atracurium besilate for injection |
| 01/30/2013 | CN102898349A Solid containing compound, a composition containing the solid and use of the solid |
| 01/30/2013 | CN102895633A Preparation technology and production method for integrated new formulation of fengyin decoction |
| 01/30/2013 | CN102895618A Preparation technology and production method for integrated new formulation of snakegourd root and cassia twig decoction |
| 01/30/2013 | CN102895613A Preparation technology and production method for integrated new formulation of cassia twig plus kudzu root decoction |
| 01/30/2013 | CN102895481A Medicine for treating flaccidity syndrome |
| 01/30/2013 | CN102895457A Preparation technology and production method for integrated new formulation of golden chamber kidney qi pill |
| 01/30/2013 | CN102895335A Preparation technology and production method for integrated new formulation of radix aconiti lateralis preparata powder |
| 01/30/2013 | CN102895311A Preparation method of illicium henryi injecta |
| 01/30/2013 | CN102895214A Solid pharmaceutical composition of levetiracetam tablet |
| 01/30/2013 | CN102432662B Crystal form of pipecuronium bromide, preparation method and application of crystal form |
| 01/30/2013 | CN102228696B Polyethylene glycol-polyvinyl alcohol copolymer-metaxalone prodrug and synthesis method thereof |